Document and Entity Information
Document and Entity Information | Aug. 12, 2020 |
Cover [Abstract] | |
Amendment Flag | true |
Entity Central Index Key | 0001631574 |
Document Type | 8-K/A |
Document Period End Date | Aug. 12, 2020 |
Entity Registrant Name | WAVE LIFE SCIENCES LTD. |
Entity Incorporation State Country Code | U0 |
Entity File Number | 001-37627 |
Entity Tax Identification Number | 00-0000000 |
Entity Address, Address Line One | Marina One |
Entity Address, City or Town | East Tower |
Entity Address, Country | SG |
Entity Address, Postal Zip Code | 018936 |
City Area Code | 65 |
Local Phone Number | 6236 3388 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | $0 Par Value Ordinary Shares |
Trading Symbol | WVE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Description | This Current Report on Form 8-K/A is being filed by Wave Life Sciences Ltd. (the “Company”) as an amendment (the “Amendment”) to the Current Report on Form 8-K that the Company filed with the Securities and Exchange Commission on August 18, 2020 that disclosed the preliminary voting results (the “Original Report”) of the Company’s 2020 Annual General Meeting of Shareholders on August 12, 2020 (the “Annual Meeting”). This Amendment to the Original Report is being filed to disclose the final voting results received on August 18, 2020, certified by Broadridge Financial Solutions, Inc., the independent Inspector of Elections, and amends and restates Item 5.07 of the Original Report in its entirety. |